Dear Friend of IBRF,

Few families will remain untouched in their lifetimes by such brain disorders as Alzheimer’s, Parkinson’s, Autism, Schizophrenia, Bipolar Disorder, Retardation Syndromes, ADD, Tourette’s, Multiple Sclerosis, and numerous other brain-related ailments that prevent countless people from enjoying a quality life.

I am pleased to introduce you to the International Brain Research Foundation (IBRF). As the first and only global organization supporting medical research, IBRF focuses exclusively on issues surrounding brain health. Through our network of neuroscientists and clinicians, we are developing collaborations with numerous institutions worldwide. IBRF’s global reach will allow us to discover, distribute, and share the newest scientific findings in an efficient manner, which ultimately will accelerate the scientific community’s progress in solving many of the complex, brain-related issues that humanity faces today.

The catalyst to create IBRF was my desire to modify the current reality surrounding grant-based research. The typical research scientist today faces a myriad of obstacles in trying to obtain grants. On average, 40-68% of monies that are donated to research today are consumed by operational overhead. In addition, scientists are often encumbered by time-consuming, non-productive administrative tasks required to secure and maintain such funding. IBRF has streamlined this process and eliminated many of the burdens associated with grant-based funding by supporting research collaborations, allowing scientists to devote nearly 100% of their time to their respective research efforts.

We are currently collaborating with the Neurosurgery Department of the University of Medicine and Dentistry of New Jersey to establish a second NACU site. Additionally, the IBRF and UMDNJ are developing the concept for an advanced neurotrauma center that will facilitate rapid intervention for traumatic brain injury and stroke syndromes.

The next major area of concern on IBRF’s research agenda will focus on autism spectrum disorders. A task force has been developed to design a blueprint for translational clinical research within this group of disorders.

With a well-capitalized budget structure, I feel strongly that IBRF can dramatically influence significant advances in the treatment of brain disorders. Corporate and private funding, however, is a critical component to our mission.

We look forward to your interest and support of our cutting-edge research programs, which already have demonstrated that translational clinical research can result in practical application of timely interventions for individuals suffering from complex brain syndromes.

Thank you in advance for your interest. Please feel free to contact us for more information.

Sincerely,

Philip A. De Fina, Ph.D.
Chief Executive Officer
Chief Scientific Officer